Skip to main content

Advertisement

SpringerLink
Log in

Preventing NSAID-Induced Gastrointestinal Toxicity

Economic Considerations, Methodological Problems and Results

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grahum DY, Agrawal NM, Rolh SH. Prevention of NSAID–induced gastric ulcer with misoprostol: a multicenter doubleblind, placebo–controlled trial. Lancet 1988; 2: 1277–80

    Article  Google Scholar 

  2. Grahum DY, Stromatt SC, Jaszewski R, et al. Prevention of duodenal ulcer in anthritics who are chronic NSAID users: a multicenter trial of the role; of misoprostol [abstract A75]. Gastroenterology 1991; 100 Suppl.: 75

    Google Scholar 

  3. Bolten W, de Melo Gomes JA, Stead H, et al. The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis. Br J Rheumatol 1992; 31: 753–8

    Article  PubMed  CAS  Google Scholar 

  4. de Melo Gomes JA. The safety of Arthrotec® in patients with rheumatoid anhritis or osteoarthritis: an assessment of the upper gastrointestinal tract by endoscopy. Scand J Rheumatol 1992: 21 Suppl 96: 27–36

    Google Scholar 

  5. Verdickt W, Moran C, Hantzschel H. A double–blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac: and misoprostol in tho treatment of rheumatoid arthritis. Scand J Rheumatol 1992; 21: 85–91

    Article  PubMed  CAS  Google Scholar 

  6. Ehsanullah RSB, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non–steroidal anti–inflammatory drugs: controlled trial of ramitidine. BMJ 1988; 297: 1017–21

    Article  PubMed  CAS  Google Scholar 

  7. Oddsson E, Gudjonsson H, Thjodleifsson B. Protective effect of omeprazole or ranitidine against naproxen–induced damage to the human gastroduodenal mucosa [abstract]. Scand J Gastroenterol 1990: 25 Suppl.176: 13

    Google Scholar 

  8. Barradell LB, Whittington R, Benfield P. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti–inflammatory drugs. Pharmacoeconomic 1993; 3: 140–70

    Article  CAS  Google Scholar 

  9. Lecomte T. La consommalion pharmaceutique: structure, prescription et motifs. France 1970-1980. Paris: CREDES, 1985: 665

    Google Scholar 

  10. Anonymous. Evolution de la morbidité déclarée, France 1970-1980. Paris: CREDES, 1986: 4884/630

  11. Bergmann JF, Pichot L, de Pouvourville G, et al. Prévention des lésions gastro–duodénales induites par les anti–inflammatories non–stéroïdiens; analyse ékonomique à partir d’un sondage réalisé chez 356 médecins. Presse Med 1991; 21: 983–6

    Google Scholar 

  12. Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 18 Suppl. 28: 6–10

    Google Scholar 

  13. Somerville KW, Hawkey CJ, Non–steroidal anti–inflammatory agents and the: gastrointestinal tract. Postgrad Med J 1986: 62: 23–8

    Article  PubMed  CAS  Google Scholar 

  14. Wood JJ. Misoprostol for the treatment of peptic ulcer and anti–inflammatory drug induced gastroduodenal ulceration. N Engl J Med 1992: 332: 1575–80

    Article  Google Scholar 

  15. Gabriel SE, Bombardier C, NSAID induced ulcers: an emerging epidemic? J Rheumatol 1990; 17: 1–4

    PubMed  CAS  Google Scholar 

  16. Duhamel C, Czernichow P, Ducrotté P, et al. Hémorragies digestives hautes sous anti–inflammatoires (AI). Gastroenterol Clin Biol 1989: 13: 239–44

    PubMed  CAS  Google Scholar 

  17. Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med 1988; 84 Suppl. 2A: 20–4

    Article  Google Scholar 

  18. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti–inflammatory drugs. Arch Intern Med 1988: 149: 1019–22

    Article  Google Scholar 

  19. Kolodny AL, Klipper A. Final report on the cost of treating arthritic disease: comparison between salicylates and non–salicylates non steroidal antiinflammatory drugs. Semin Arthritis Rheum 1985: 14 (3 Suppl. 1): 20–4

    Article  Google Scholar 

  20. Gabriel SE. Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of nonsteroidal anti–inflammatory drugs. Ann Intern Med 1991; 115: 787–96

    PubMed  CAS  Google Scholar 

  21. Delmas PD, Lambert R, Ethevenaux C. et al. Prevention of NSAID induced gastric and duodenal lesions with misoprostol [abslract D109]. Arthritis Rheum 1990; 33 Suppl.: 5152

    Google Scholar 

  22. Geis GS, Stead H, Wallemark CB. et al. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, an interim report on prevention by misoprostol of diclofenac associated lesions. J Rheum 1991: 18 Suppl. 28: 11–4

    Google Scholar 

  23. Agrawal NM. Making sense of NSAID gastropathy and considering the therapeutic options. Scand J Rheumatol 1992; 21 Suppl.92: 13–9

    Article  Google Scholar 

  24. de Melo Gomes JA, Roth SH, Zeeh J, et al. Double blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis. Ann Rheum Dis 1993; 42: 881–5

    Article  Google Scholar 

  25. Armstrong CP, Blower AL. Non–steroidal anti–inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28: 527–32

    Article  PubMed  CAS  Google Scholar 

  26. Matthewson K, Pugh S, Northfield TC. Which peptic ulcer patiens bleed? Gut 1988: 29: 10–4

    Article  Google Scholar 

  27. Edelson JT, Tosteson ANA, Sax P. Cost–effectiveness of misoprostol for prophylaxis against nonsteroidal anti–inflammatory drug–induced gastrointestinal tract bleeding. JAMA 1990; 4; 41–7

    Article  Google Scholar 

  28. Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking: nonsteroidal anti–inflammatory drugs. Arch Interirn Med 1989; 149: 2061–5

    Article  CAS  Google Scholar 

  29. de Pouvourville G, Bader JP. Analyse économique du traitement préventif par Ie misoprostol chez I’homme des ulcères gastriquess liés aux anti–inflammatoires non stéroïdiens. Gastroenterol Clin Biol 1991; 15: 399–404

    PubMed  Google Scholar 

  30. de Pouvourville G. Lésions digestives dues aux AINS: analyse économique. Impact Med 1992; 145: 18–23

    Google Scholar 

  31. Carrin G, Torfs KE. Economic evaluation of prophylactic treatment with misoprostol in osteoarthritic patients treated with NSAIDs: the case of Belgium. Rev Epidemiol Sante Publique 1990: 38: 197–9

    Google Scholar 

  32. Knill-Jones R, Drummond M, Kohli H. et al. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving nonsteroidal anti–inflammatory drugs. Postgrad Med J 1990; 66: 639–46

    Article  PubMed  CAS  Google Scholar 

  33. Jönsson B, Haglund U. Cost–effectiveness of misoprostol in Sweden. Int J Technol Assess Health Care 1992: 8: 234–44

    Article  PubMed  Google Scholar 

  34. Gabriel S, Jaakkimainen RL, Bombardier C. The cost–effectiveness of misoprostol for non–steroidal antiinflammatory drug–associated adverse gastrointestinal events. Arthritis Rheum 1993: 36: 447–59

    Article  PubMed  CAS  Google Scholar 

  35. Gabriel SE, Campion ME, O’Fallon WM. A cost–utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 1994: 31: 333–41

    Article  Google Scholar 

  36. Geis GS. Overall safety of Arthrotec. Scand J Rheumatol 1992: 21 Suppl. 96: 37–40

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Recherche en Gestion, École Polytechnique, 1 rue Descartes, 75005, Paris, France

    Gérard de Pouvourville

Authors
  1. Gérard de Pouvourville
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Pouvourville, G. Preventing NSAID-Induced Gastrointestinal Toxicity. Pharmacoeconomics 7, 99–110 (1995). https://doi.org/10.2165/00019053-199507020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507020-00002

Keywords

Search

Navigation